These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24767353)

  • 1. Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal biopsy.
    Fujinaga K; Usui M; Yamamoto N; Ishikawa E; Nakatani A; Kishiwada M; Mizuno S; Sakurai H; Tabata M; Isaji S
    Transplant Proc; 2014 Apr; 46(3):804-10. PubMed ID: 24767353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation.
    Matsui T; Usui M; Fujinaga K; Nakatani K; Iizawa Y; Kato H; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1184-9. PubMed ID: 27320583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.
    Garcia-Retortillo M; Forns X; Llovet JM; Navasa M; Feliu A; Massaguer A; Bruguera M; Fuster J; Garcia-Valdecasas JC; Rimola A
    Hepatology; 2004 Sep; 40(3):699-707. PubMed ID: 15349910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation.
    Abe T; Onoe T; Tahara H; Tashiro H; Ishiyama K; Ide K; Ohira M; Ohdan H
    Transplant Proc; 2014 Apr; 46(3):865-9. PubMed ID: 24767367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early postoperative renal dysfunction in the adult living donor liver transplantation.
    Lee SK; Park JB; Kim SJ; Choi GS; Kim DJ; Kwon CH; Lee SK; Joh JW
    Transplant Proc; 2007 Jun; 39(5):1517-9. PubMed ID: 17580177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus after living donor liver transplantation: data from mainland China.
    Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
    Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.
    Gaglio PJ; Malireddy S; Levitt BS; Lapointe-Rudow D; Lefkowitch J; Kinkhabwala M; Russo MW; Emond JC; Brown RS
    Liver Transpl; 2003 Oct; 9(10):1028-35. PubMed ID: 14526396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is recurrent hepatitis C worse with living donors?
    Kuo A; Terrault NA
    Curr Opin Organ Transplant; 2009 Jun; 14(3):240-4. PubMed ID: 19395968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.
    Iwata H; Mizuno S; Ishikawa E; Tanemura A; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Tabata M; Yamamoto N; Sugimoto K; Shiraki K; Takei Y; Ito M; Isaji S
    Transplant Proc; 2014 Apr; 46(3):716-20. PubMed ID: 24767332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset diabetes mellitus after living donor liver transplantation: possible association with hepatitis C.
    Kishi Y; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Makuuchi M
    Transplant Proc; 2006 Nov; 38(9):2989-92. PubMed ID: 17112882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts.
    Krieger NR; Becker BN; Heisey DM; Voss BJ; D'Alessandro AM; Becker YT; Odorico JS; Kalayoglu M; Pirsch JD; Sollinger HW; Knechtle SJ
    Transplantation; 2003 May; 75(10):1677-82. PubMed ID: 12777855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.